miércoles, 6 de febrero de 2019

Recalls, Market Withdrawals, & Safety Alerts > Dr. Reddy's Laboratories Continues its Voluntary Nationwide Recall of Levetiracetam in 0.54% Sodium Chloride Injection 1500mg/100mL Due to Mislabeling

Recalls, Market Withdrawals, & Safety Alerts > Dr. Reddy's Laboratories Continues its Voluntary Nationwide Recall of Levetiracetam in 0.54% Sodium Chloride Injection 1500mg/100mL Due to Mislabeling





A new MedWatch Safety Alert recall: Levetiracetam in 0.54% Sodium Chloride Injection 1500mg/100mL by Dr. Reddy's Laboratories: Recall - Due to Mislabeling was just added to the FDA Recalls webpage.
 
You can read the complete recall alert at: https://www.fda.gov/Safety/Recalls/ucm630542.htm

No hay comentarios: